Nucleus Software Exports Limited (NSE: NUCLEUS, BSE: 531209), a leading global provider of software products for banks and financial institutions today announced that its product FinnOne™ is ranked once again as the ‘World’s No. 1 Selling Lending Software Product’ by International Banking Systems (IBS), UK, in its annual Sales League Table for the year 2010.
Published by IBS Publishing, the IBS Sales League Table independently tracks financial product market and is based on a worldwide annual survey of sales of corporate, retail and private banking solutions. IBS Publishing is an independent research and publishing house dedicated to news, research and analysis covering banking operations and systems internationally.
This is the second consecutive year that FinnOne™ has been ranked at the top and fifth consecutive year that the product has been ranked amongst world’s best selling lending software products; the ranking is based on the number of sales made in the calendar year. FinnOne™, ranked best in the lending category, emerged a winner with 13 global sales for year 2009, far ahead of its other competitors in this segment.
With this recognition FinnOne™ re-instates its global leadership position.
FinnOne™, the flagship product of Nucleus Software, is a powerhouse of seamlessly integrated applications, designed to provide operational support, risk management and decision-making support to banks and financial services companies. The FinnOne™ suite provides solutions for the asset as well as liability sides of business in addition to account management, core financial accounting, risk management, document management, and customer services. FinnOne™ also supports multi-branch, multi-currency, multi-product, and bi-lingual implementations. FinnOne™ focuses on both, retail and corporate loans, thereby emerging as a comprehensive solution to back any line of the lending business.
On this occasion Vishnu Dusad, CEO & MD, Nucleus Software, said, “We are extremely delighted and is a matter of great pride for us that our flagship product retained the No.1 position in the lending segment across the globe. The ranking re-instates Nucleus’ leadership position as the creators of World’s best selling lending software product and is a strong endorsement of our vision, mission and commitment to customer satisfaction. Nucleus’ vision is to be leading global end-to-end products & solution provider; a customer-oriented global organization committed to the highest level of quality for its products and services. As one of the largest IP creators in the country this recognition encourages us to continue on our path to take technology to the next level and provide our customers with the very best in banking solutions and thus empower them with a distinct business advantage.”
About IBS Publishing:
The IBS Sales League Table is compiled by IBS Publishing, UK based on a worldwide survey of sales of banking solutions to new named banking wins in the calendar year including Commercial, Retail and Private banking solutions. IBS is an independent research and publishing house dedicated to the wholesale, retail and private banking systems market. This survey is increasingly recognized globally as the only one of its kind that independently tracks the financial products marketplace. IBS is known for their objective coverage of the financial services systems market, cutting through supplier hype, with investigative news, features and surveys.
About Nucleus Software Export Limited:
Nucleus Software (NSE: NUCLEUS, BSE: 531209) is a leading software powerhouse providing innovative and pioneering software solutions for Banks and Financial organizations globally. Nucleus Software offers a host of competitive IT solutions and consultancy services designed to support the whole spectrum of business offerings spanning Retail and Corporate Banking, Cash Management, Credit Cards, Relationship Banking, Financial CRM, Credit Risk & Appraisal, EAI, Internet Banking, FX, Basel II, Data warehousing and Analytics. The company is consistently innovating with cutting edge and industry driven products in the domain. Nucleus Software is listed on the National Stock Exchange and Bombay Stock Exchange in India. For more information, visit www.nucleussoftware.com
Certain statements in this release concerning our future growth prospects are forward-looking statements, which involve a number of risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding the success of our investments, risks and uncertainties regarding fluctuations in earnings, our ability to manage growth, our ability to successfully implement our strategy, our research and development efforts, changes in the value of the Rupee and other currency changes, intense competition in IT and consulting services including those factors which may affect our cost advantage, wage increases in India, our ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, restrictions on immigration, industry segment concentration, our ability to manage our international operations, reduced demand for technology in our key focus areas, disruptions in telecommunication networks or system failures, our ability to successfully complete and integrate potential acquisitions, liability for damages on our service contracts, withdrawal of governmental fiscal incentives, political instability and regional conflicts, legal restrictions on raising capital or acquiring companies outside India, and unauthorized use of our intellectual property and general economic conditions affecting our industry. Nucleus may, from time to time, make additional written and oral forward-looking statements, including statements contained in the company’s filings with the Securities and Exchange Board of India, Stock Exchange and our reports to shareholders. The company does not undertake to update any forward-looking statements that may be made from time to time by or on behalf of the company.